Abstract Details
|
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Christophe Vial (Hopital Neurologique) | No disclosure on file |
| Emilien Delmont, MD | No disclosure on file |
| No disclosure on file | |
| Jean-Christophe Antoine, MD (CHU De St Etienne) | No disclosure on file |
| No disclosure on file | |
| Thierry Kuntzer, MD (Lausanne University Hospital CHUV) | No disclosure on file |
| Antoine Gueguen, MD (Fondation Oph. A. De Rothschild, Service De Neurologie) | An immediate family member of Dr. Gueguen has received personal compensation for serving as an employee of ABBVIE. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Jonhson&Jonhson. Dr. Gueguen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. The institution of Dr. Gueguen has received research support from BrainEver. The institution of Dr. Gueguen has received research support from Pixyl. The institution of Dr. Gueguen has received research support from Kalsiom. The institution of Dr. Gueguen has received research support from Ministére de la Santé, France. |
| Jean-Phillippe Camdessanche | Jean-Phillippe Camdessanche has nothing to disclose. |